J-Pharma Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024
Period Ending	Jun '26 Jun 3, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024
Market Capitalization	7,463	12,998	-	-
Enterprise Value	3,010	10,696	-	-
Last Close Price	415.00	729.00	-	-
PB Ratio	1.70	2.97	-	-
P/TBV Ratio	1.70	2.97	-	-
Net Debt / Equity Ratio	-1.02	-1.02	-0.97	-1.13
Net Debt / EBITDA Ratio	1.20	1.20	1.44	0.62
Net Debt / FCF Ratio	1.98	1.98	1.36	0.76
Quick Ratio	11.90	11.90	5.13	5.49
Current Ratio	12.57	12.57	6.28	5.96
Return on Equity (ROE)	-73.01%	-73.01%	-90.09%	-
Return on Assets (ROA)	-60.88%	-60.88%	-49.08%	-
Return on Capital Employed (ROCE)	-84.60%	-84.60%	-66.40%	-171.00%
Earnings Yield	-33.05%	-18.98%	-	-
FCF Yield	-30.19%	-17.33%	-	-
Buyback Yield / Dilution	-	-55.23%	-29.92%	-